^
Association details:
Evidence:
Evidence Level:
Sensitive: C3 – Early Trials
Title:

Comprehensive analysis of the prognosis and biological significance for IFIT family in skin cutaneous melanoma

Published date:
11/08/2021
Excerpt:
Furthermore, drug sensitivity analysis indicated that the high expression of IFIT1/2/3 was sensitive to dasatinib drug....IFITs may serve as novel biomarkers for the diagnosis and prognosis of melanoma and potential immunotherapeutic targets.
DOI:
10.1016/j.intimp.2021.108344